Anemia to Blood Donors at the National Blood Transfusion Center of Abidjan Cote D'Ivoire
European Journal of Clinical and Biomedical Sciences
Volume 6, Issue 1, February 2020, Pages: 1-4
Received: Dec. 28, 2019;
Accepted: Jan. 6, 2020;
Published: Jan. 16, 2020
Views 386 Downloads 149
Sekongo Yassongui Mamadou, Department of Training and Research, National Blood Transfusion Center, Abidjan, Côte d’Ivoire
Kabore Saydou, Laboratory of Quality Control, National Blood Transfusion Center, Abidjan, Côte d’Ivoire
Yao Kouadio Daniel, Quality Management System, National Blood Transfusion Center, Abidjan, Côte d’Ivoire
Dembele Bamory, Laboratory of Biology Qualification, National Blood Transfusion Center, Abidjan, Côte d’Ivoire
Konate Seidou, Director of the NBTC, National Blood Transfusion Center, Abidjan, Côte d’Ivoire
Dasse Sery Romuald, Head of Immunology-allergology Service, Hospitality and University Center of Cocody, Abidjan, Côte d’Ivoire
Blood transfusion is an essential replacement therapy which many patients benefit from during various medical and surgical pathologies. However, transfusion therapy is associated with complications including the risk of iron deficiency anemia to blood donors in whom the pre-donation haemoglobin dosage is an important parameter of transfusion safety. This study therefore aims to determine the prevalence of anemia among blood donors at Côte d’Ivoire National Blood Transfusion Center. This prospective cross-sectional study took place from September 01 to October 31, 2015 at Abidjan National Blood Transfusion Center in Côte d’Ivoire and concerned 50 samples of regular blood donors excluded solely because of anemia out of a total of 1200 regular donors. After the consultation te excluded donor is then taken on an EDTA tube to perform an haemogram on an automated device and from a dry tube which will be used for the determination of ferritinemia. Statistical analyzes were carried out using Epi Info 6.04, Excel and the Chi-square test. The prevalence of anemia to our blood donor was 3.85%. The Hb level was significantly lower to women than men (p = 0.048) and more frequent anemia beyond 10 donations. The anemia was hypochromic microcytic to 31 donors (62%), hypochromic normocytic to 2 donors (4%), normochromic normocytic to 17 donors (34%). Martial assessment was performed to 31 donors and ferritin was lowered to 22 donors indicating the absence of an iron reserve. The prevalence of anemia to Côte d’Ivoire blood donors is 3.85%. Anemia to regular blood donors is mainly due to an iron deficiency. This deficiency is correlated with sex and the number of donations. Iron IV has been shown to be more effective than oral iron in the treatment of iron deficiency anemia in blood donors.
Sekongo Yassongui Mamadou,
Yao Kouadio Daniel,
Dasse Sery Romuald,
Anemia to Blood Donors at the National Blood Transfusion Center of Abidjan Cote D'Ivoire, European Journal of Clinical and Biomedical Sciences.
Vol. 6, No. 1,
2020, pp. 1-4.
Copyright © 2020 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/
) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
WHO. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity: Vitamin and Mineral Nutrition Information System. Geneva: World Health Organization; 2011.
McLean E, Cogswell M, Egli I, Wojdyla D, De Benoist B. Worldwide prevalence of anemia, WHO Vitamin and Mineral Nutrition Infromation System, 1993-2005. Public Health Nutr. 2009 Apr; 12 (4): 444–54.
-B. Danic Mise au point. Enoncer les conditions d’un don de sang standard et les motifs d’exclusion. Transfusion clinique et biologique 12 (2005) 287-289.
WHO Sécurité transfusionnelle et approvissionnement en sang. World Health Organization; Juin 2017. https://www.who.int/fr/news-room/fact-sheets/detail/blood-safety-and-availability.
Jeremiah ZA, Koate BB. Anaemia, iron deficiency and iron deficiency anaemia among blood donors in Port Harcourt, Nigeria. Blood Transfusion. 2010; 8 (2): 113–7.
Mittal R, Marwaha N, Basu S, et al. Evaluation of iron stores in blood donors by serum ferritin. Indian J Med Res. 2006; 124 (6): 641–6.
Diarra A. Anémie chezta les donneurs de sang réguliers au CNTS de Bamako. Thèse, Pharm. Bamako 2006.
Mohamed A. B. Prévalence de l’anémie chez les donneurs de sang au Centre National de Transfusion Sanguine de Nouakchott; Master de Santé Publique 2013.
Lee CK, Wong HK, Hong J, et al. A study of the predonation hemoglobin and iron status among Hong Kong Chinese blood donors. Transfusion. 2013; 53 (2): 322–7.
Franck Nzengu-Lukusa, Sylvain Yuma-Ramazani, Eddy Sokolua-Mvika, Angèle Dilu-Keti, Blanchard Malenga-Nkanga, Jean Baptiste Shuli, Donatien Kayembe Nzongola-Nkasu, Ferdinand Mbayo-Kalumbu et Steve Ahuka-Mundeke Carence en fer, anémie et anémie ferriprive chez les donneurs de sang à Kinshasha, République Démocratique du Congo. Pan Afr Med J. 2016; 23: 174.
C. Tayou Tagny, A Diara, RakiaYahaya, M. Hakizamana, A. Nguessan, G. Mbensa, YacoubaNebié, H. Dahourou, J-B. Tapko, S. Shibosky, E. Murphy, J. J. Lefrére. Le centre de transfusion, le donneur de sang, et le sang donné dans les pays d’Afrique francophone. Transfusion clinique et biologique 16 (2009) 431-438.
Salvin HE, Pasricha S, Marks DC, Speedy J. Iron deficiency in blood donors: a national cross-sectional study. Transfusion. 2014; 54 (10): 2434–44. [PubMed] [Google Scholar].
Mindy Goldman, MD, FRCP (C); www.transfusionmedicine.ca/fr Publié en juillet 2013 – Page 1/11.
American Association of Blood Banks. «Strategies to Monitor, Limit, or Prevent Iron Deficiency in Blood Donors », Bulletin no 12-03. Sur .
AM Fillet, S. Gross Prevention of anemia in blood donors ransfusion clinique et biologique 2017, 24; 3: 143-147.
Kiss JE, Brambilla D, Glynn SA, Mast AE, Spencer BR, Stone M, Kleinman SH, Cable RG, National Heart L, Blood Institute Recipient E, Donor Evaluation S, III. Oral Iron Supplementation after Blood Donation: A Randomized Clinical Trial. JAMA 2015; 313: 575-83. https://www.ncbi.nlm.nih.gov/pubmed/25668261.
Krayenbuehl PA, Battegay E, Breymann C, Furrer J, Schulthess G. Intravenous Iron for the Treatment of Fatigue in Nonanemic, Premenopausal Women with Low Serum Ferritin Concentration. Blood 2011; 118: 3222-7. https://www.ncbi.nlm.nih.gov/pubmed/21705493.